Japan pharma Takeda joins forces with India’s Biological E to accelerate vaccine production
INDIA — Japan’s Takeda Pharmaceutical has entered into a strategic collaboration with...
Read More
Tag: Takeda
Rare disease company Takeda rolls out its new public health initiatives in India
INDIA – Takeda Biopharmaceuticals India Private Limited has launched its latest public health...
Read More
Takeda secures license for Celiac Disease antibodies with US$5M upfront payment
JAPAN — Takeda, a global pharmaceutical company based in Japan, is diligently expanding its...
Read More
Takeda and Hutchmed tie up on cancer drug for US$1.13B
JAPAN — Takeda, a pharmaceutical company from Japan, has partnered with Hong Kong-based Hutchmed...
Read More
Takeda acquires Nimbus Therapeutics’ subsidiary for US$6B
JAPAN — Takeda has expanded its psoriasis treatment portfolio after completing its acquisition of...
Read More
Takeda to pay up to US$6 billion for Nimbus’ mid-stage immune-therapy drug
JAPAN — Takeda Pharmaceutical has agreed to pay up to US$6 billion (813 billion) for an...
Read More
Takeda’s dengue vaccine bags EU approval, opening door for wider global use
BELGIUM—Takeda Pharmaceutical’s dengue vaccine has been authorized for use in the European Union,...
Read More
A trio of pharma giants partner with scientists in Singapore for biologics manufacturing
SINGAPORE — GSK, Sanofi, and Takeda are set to collaborate with researchers from the Agency for...
Read More
FDA selects Takeda’s dengue vaccine for speedy review
USA —The US Food and Drug Administration has begun a priority six-month review of Takeda’s...
Read More
Takeda invests US$299 million for plasma-derived therapies production in Belgium
BELGIUM – Japanese pharma major Takeda is set to invest close to 300 million euros (US$299...
Read More
Code Bio and Takeda collaborate to develop gene therapies for rare diseases
USA – Takeda has formed a new partnership with Code Biotherapeutics to gain opt-in rights for four...
Read More
LATEST DIGITAL MAGAZINE
